Table 5. Analysis of the correlation between expression of miR1273f in LC and its clinicopathological parameters.

Pathological characteristics	Cases (n)	miR1273f expression		P value
		High (4)	Low (16)
Gender				0.264
Male	10 (50%)	1 (25%)	9 (56.3%)
Female	10 (50%)	3 (75%)	7 (43.8%)
Age				0.068
<65	8 (40%)	0	8 (50%)
≥65	12 (60%)	4 (100%)	8 (50%)
Location				0.938
Left	6 (30%)	1 (25%)	5 (31.3%)
Right	11 (55%)	2 (50%)	9 (56.3%)
Others	3 (15%)	1 (25%)	2 (12.5%)
T stage				0.486
1/2	15 (75%)	3 (75%)	12 (75%)
3/4	2 (10%)	0	2 (12.5%)
Others	3 (15%)	1 (25%)	2 (12.5%)
Lymph node metastasis				0.090
No	9 (45%)	3 (75%)	6 (37.5%)
Yes	7 (35%)	0	7 (43.8%)
Others	4 (20%)	1 (25%)	3 (18.8%)
Metastasis status				0.633
No	16 (80%)	3 (75%)	13 (81.3%)
Yes	1 (5%)	0	1 (6.3%)
Others	3 (15%)	1 (25%)	2 (12.5%)
TNM stage				0.180
I/II	12 (60%)	3 (75%)	9 (56.3%)
III/IV	6 (30%)	0	6 (37.5%)
Others	2 (10%)	1 (25%)	1 (6.3%)
Histology				0.656
SCC	1 (5%)	0	1 (6.3%)
Adenocarcinoma	18 (90%)	3 (75%)	15 (93.8%)
Others	1 (5%)	1 (25%)	0
Tumor grading*				0.020
2	2 (10%)	1 (25%)	1 (6.3%)
3	10 (50%)	0	10 (62.5%)
Others	8 (40%)	3 (75%)	5 (31.3%)

^* No pathological grading of 1.